StonvexLoading…
StonvexStonvexStonvexCore line items from RKDA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $4.86M | $5.04M | $4.45M | $7.42M |
Operating Income | $-2.50M | $-3.65M | $-6.10M | $-14.01M |
Net Income | $-2.34M | $-7.04M | $-13.98M | $-15.38M |
EPS (Diluted) | $-1.71 | $-5.17 | $-11.29 | $-25.65 |
Total Assets | $6.55M | $13.52M | $19.70M | $28.92M |
Total Liabilities | $2.41M | $7.29M | $7.00M | $8.02M |
Cash & Equivalents | $259.00K | $4.24M | $6.52M | $20.64M |
Free Cash Flow OCF − CapEx | $-4.74M | $-9.64M | $-15.30M | $-14.05M |
Shares Outstanding | 1.37M | 1.36M | 1.29M | 616.08K |